Through in vitro and in vivo experiments, we disclosed that NCD upregulates the TIME-GES genes CXCL10, CXCL11, EBI3, and FLT3LG, promotes CD8+ T cell activation and tumor infiltration, thereby inhibiting the growth of TNBC. The gene discussed is FLT3LG; the disease is neoplasm.